Re “Inhaled Corticosteroid Particle Size and Risk of Hospitalization Rue to Exacerbations and All-Cause Mortality in Patients With Chronic Obstructive Respiratory Disease. A Nationwide Cohort Study”. Heerfordt et al [Letter]
Richard Hubbard, Victoria Carter, William Henley, David Price Observational and Pragmatic Research Institute, Cambridge, UKCorrespondence: David Price, Observational and Pragmatic Research Institute, 5 Coles Lane, Cambridge, CB24 3BA, UK, Email dprice@opri.sg
Saved in:
Main Authors: | Hubbard R, Carter V, Henley W, Price D |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-02-01
|
Series: | International Journal of COPD |
Subjects: | |
Online Access: | https://www.dovepress.com/re-ldquoinhaled-corticosteroid-particle-size-and-risk-of-hospitalizati-peer-reviewed-fulltext-article-COPD |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of patient compliance with inhaler therapy on chronic obstructive pulmonary disease severity: a rural tertiary care perspective
by: Nandakishore K. S., et al.
Published: (2025-02-01) -
Inhaled corticosteroids in asthma and chronic obstructive pulmonary disease combined phenotype: when to use and what to expect?
by: Srishankar Bairy, et al.
Published: (2025-01-01) -
Post-Acute Care Interventions in Patients Hospitalized Due to COPD Exacerbation Before and After Implementation of an Integrated Care Program
by: Hübsch C, et al.
Published: (2025-01-01) -
Association of Corticosteroid Inhaler Type with Saliva Microbiome in Moderate-to-Severe Pediatric Asthma
by: Amir Hossein Alizadeh Bahmani, et al.
Published: (2025-01-01) -
Nighttime Cough Characteristics in Chronic Obstructive Pulmonary Disease Patients
by: Albertus C. den Brinker, et al.
Published: (2025-01-01)